Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
37
datasets available to search
ShareScore release 0.9.0
Dataset results
37 results for “DCE-MRI”
DCE-MRI DRO Data (Daniel Barboriak)
<p>This is the digital reference object (DRO) data created to validate software build to analyse DCE-MRI with the General Kinetic Model (GKM) or extended GKM (eGKM) as well as software for evaluating T1 mapping using the variable flip angle (VFA) method.</p><p>The data has been produced for the Quantitative Imaging Biomarkers Alliance (QIBA) and was moved from the retired Quantitative Imaging Data Warehouse (QIDW).</p><p>It can be used to evaluate software packages for their conformance to the quantitative DCE-MRI Profile 2.0 soon to be release. </p>
FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer
ClinicalTrials.gov study NCT01931709. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Data from: Assessment of tumor treatment response using active contrast encoding (ACE)-MRI: comparison with conventional DCE-MRI
<p><strong>Purpose:</strong> To investigate the validity of contrast kinetic parameter estimates from Active Contrast Encoding (ACE)-MRI against those from conventional Dynamic Contrast-Enhanced (DCE)-MRI for evaluation of tumor treatment response in mouse tumor models.</p> <p><strong>Methods:</strong> The ACE-MRI method that incorporates measurement of <em>T<sub>1</sub></em> and <em>B<sub>1</sub></em> into the enhancement curve washout region, was implemented on a 7T MRI scanner to measure tracer kinetic model parameters of 4T1 and GL261 tumors with treatment using bevacizumab and 5FU. A portion of the same ACE-MRI data was used for conventional DCE-MRI data analysis with a separately measured pre-contrast <em>T<sub>1</sub></em> map. Tracer kinetic model parameters, such as <em>K<sup>trans</sup></em> (permeability area surface product) and <em>v<sub>e</sub></em> (extracellular space volume fraction), estimated from ACE-MRI were compared with those from DCE-MRI, in terms of correlation and Bland-Altman analyses. </p> <p><strong>Results:</strong> A three-fold increase of the median <em>K<sup>trans</sup></em> by treatment was observed in the flank 4T1 tumors by both ACE-MRI and DCE-MRI. In contrast, the brain tumors did not show a significant change by the treatment in either ACE-MRI or DCE-MRI. <em>K<sup>trans</sup></em> and <em>v<sub>e</sub></em> values of the tumors from ACE-MRI were strongly correlated with those from DCE-MRI methods with correlation coefficients of 0.92 and 0.78, respectively, for the median values of 17 tumors. The Bland-Altman plot analysis showed a mean difference of -0.01 /min for <em>K<sup>trans</sup></em> with the 95% limits of agreement of -0.12 /min to 0.09 /min, and -0.05 with -0.37 to 0.26 for <em>v<sub>e</sub></em>.</p> <p><strong>Conclusion:</strong> The tracer kinetic model parameters estimated from ACE-MRI and their changes by treatment closely matched those of DCE-MRI, which suggests that ACE-MRI can be used in place of conventional DCE-MRI for tumor progression monitoring and treatment response evaluation with a reduced scan time. <br> </p>
DCE-MRI and DWI for Detection and Diagnosis of Breast Cancer
ClinicalTrials.gov study NCT02022579. IPD Sharing: YES. Countries: 1. Publications: 1.
Data from: Assessment of tumor treatment response using active contrast encoding (ACE)-MRI: comparison with conventional DCE-MRI
Open the record for dataset details and reuse information.
Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom
ClinicalTrials.gov study NCT05140902. IPD Sharing: NO. Countries: 1. Publications: 0.
DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors
ClinicalTrials.gov study NCT00978562. IPD Sharing: Not stated. Countries: 1. Publications: 0.
DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC
ClinicalTrials.gov study NCT01806740. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Suitability of DCE-MRI for Detection of Vascular Changes After VBT
ClinicalTrials.gov study NCT01991808. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis
ClinicalTrials.gov study NCT00361634. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Integrative analysis of DCE-MRI and gene expression profiles in construction of a gene classifier for assessment of hypoxia-related risk of chemoradiotherapy failure in cervical cancer
GEO Series GSE72723. Homo sapiens. 302 samples. Type: Expression profiling by array.
Breast_Cancer_DCE-MRI_Data
<p>The dataset was specifically created for use in deep learning-aided segmentation tasks for breast cancer diagnosis. It comprises 100 cases obtained from Yunnan Cancer Hospital, each containing dynamic contrast-enhanced MRI (DCE-MRI) images with six phases, consisting of one pre-contrast image and five post-contrast images. Additionally, each case includes a breast tumor annotation (ground-truth image) and a whole breast annotation for accurate segmentation.</p>
Dynamic Contrast Enhanced MRI(DCE-MRI)of Bone Tumors
ClinicalTrials.gov study NCT00598741. IPD Sharing: Not stated. Countries: 1. Publications: 0.
DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer
ClinicalTrials.gov study NCT06173310. IPD Sharing: NO. Countries: 1. Publications: 0.
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases
ClinicalTrials.gov study NCT02967380. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Monitoring Response to Neoadjuvant Chemotherapy in Breast Cancer Using Ultrafast DCE-MRI
ClinicalTrials.gov study NCT05744518. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma
ClinicalTrials.gov study NCT00352521. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Radiomics Model Based on DCE-MRI and Ultrasound Images for Breast Lesion Classification
ClinicalTrials.gov study NCT06497023. IPD Sharing: NO. Countries: 1. Publications: 0.
Comparison Of DIR-MRI And DCE-MRI In Detection Of Prostate Cancer: A Pilot Study
ClinicalTrials.gov study NCT02939456. IPD Sharing: NO. Countries: 1. Publications: 0.
Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab
ClinicalTrials.gov study NCT02992301. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.